AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21834455 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary preschool early intervention program for 8 months
Number of subjects: 81
Study 21834455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 81
Study 19320625 — intervention group
Group type: EXPERIMENTAL
Intervention: B-BAES (Brief Biphasic Alcohol Effects Scale)
Number of subjects: 190
Study 19320625 — intervention group
Group type: EXPERIMENTAL
Intervention: BAES (Biphasic Alcohol Effects Scale)
Number of subjects: 190
Study 16689086 — intervention group
Group type: EXPERIMENTAL
Intervention: Central neurotropic preparations in addition to routine medicines
Number of subjects: 181
Study 16689086 — intervention group
Group type: COMPARATOR
Intervention: Routine preparations only
Number of subjects: 181
Study 15077084 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 921
Study 15077084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study 11808574 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) training at -4.0 kPa for 1 hour per day during the last week of HDT.
Number of subjects: 12
Study 11808574 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 12
Study 9386016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle tactile contact
Number of subjects: 0
Study 9386016 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision availability
Number of subjects: 0
Study 9386016 — intervention group
Group type: EXPERIMENTAL
Intervention: Touch and vision interaction
Number of subjects: 0
Study 7969280 — intervention group
Group type: COMPARATOR
Intervention: 0.45% saline
Number of subjects: 78
Study 7969280 — intervention group
Group type: EXPERIMENTAL
Intervention: saline plus mannitol
Number of subjects: 78
Study 7969280 — intervention group
Group type: EXPERIMENTAL
Intervention: saline plus furosemide
Number of subjects: 78
Study 7969280 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 78
Study 3304988 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2 mm bipolar diathermy probe
Number of subjects: 44
Study 3304988 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 44
Study 29979803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone and acetaminophen PRN
Number of subjects: 79
Study 29979803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone and acetaminophen with specific dosing
Number of subjects: 79
Study 29979803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone, acetaminophen, and OxyContin with specific dosing
Number of subjects: 79
Study 29979803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone, acetaminophen, and ketorolac with specific dosing
Number of subjects: 79
Study 26190830 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous agar‐filled needle with calomel (Ndl)
Number of subjects: 29
Study 26190830 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal abrasion with conducting cream and Ag/AgCl electrodes (Abr)
Number of subjects: 29
Study 26190830 — intervention group
Group type: COMPARATOR
Intervention: Both methods (Ndl and Abr)
Number of subjects: 29
Study 24636266 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic therapy
Number of subjects: 105
Study 24636266 — intervention group
Group type: COMPARATOR
Intervention: Standard guidelines for antibiotic therapy (Control)
Number of subjects: 105
Study 22120765 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized L-epinephrine 0.5 ml
Number of subjects: 96
Study 22120765 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized L-epinephrine 2.5 ml
Number of subjects: 96
Study 22120765 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized L-epinephrine 5 ml
Number of subjects: 96
Study 20679654 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrollment in the Oregon Medicaid program
Number of subjects: 0
Study 20679654 — intervention group
Group type: COMPARATOR
Intervention: Waiting list for Oregon Medicaid program
Number of subjects: 0
Study 18653305 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured education
Number of subjects: 103
Study 18653305 — intervention group
Group type: EXPERIMENTAL
Intervention: Steps per day
Number of subjects: 103
Study 18653305 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 103
Study 16284031 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 16284031 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-stratified approach
Number of subjects: 0
Study 12187023 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon gamma-1b (IFN-gamma), given subcutaneously at a dose of 50 microg/m(2) daily for 30 days.
Number of subjects: 38
Study 12187023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 10703408 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal Care manual of the Perinatal Education Programme (PEP)
Number of subjects: 0
Study 8697717 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate meal (2.5 MJ)
Number of subjects: 9
Study 8697717 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat meal (2.5 MJ)
Number of subjects: 9
Study 8697717 — intervention group
Group type: EXPERIMENTAL
Intervention: Both meals
Number of subjects: 9
Study 8697717 — intervention group
Group type: COMPARATOR
Intervention: Healthy age-matched control subjects
Number of subjects: 9
Study 1767176 — intervention group
Group type: EXPERIMENTAL
Intervention: Troxerutin (4 g/d)
Number of subjects: 60
Study 1767176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 6753447 — intervention group
Group type: EXPERIMENTAL
Intervention: dl-propranolol
Number of subjects: 24
Study 6753447 — intervention group
Group type: COMPARATOR
Intervention: d-propranolol
Number of subjects: 24
Study 6753447 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 31140666 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotype threat message
Number of subjects: 77
Study 31140666 — intervention group
Group type: COMPARATOR
Intervention: Control message
Number of subjects: 77
Study 29210845 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep hypnosis session
Number of subjects: 66
Study 29210845 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 66
Study 27315354 — intervention group
Group type: EXPERIMENTAL
Intervention: truth FinishIt brand equity scale
Number of subjects: 0
Study 25162332 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-reinforced composite retainer
Number of subjects: 30
Study 25162332 — intervention group
Group type: COMPARATOR
Intervention: Spiral wire retainer
Number of subjects: 30
Study 25162332 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic examination
Number of subjects: 30
Study 22819265 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose)
Number of subjects: 60
Study 22819265 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (300 mg loading dose)
Number of subjects: 60
Study 19914566 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil (5-FU) based adjuvant chemotherapy
Number of subjects: 0
Study 19914566 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study 18091485 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary lifestyle interventions for hypertension
Number of subjects: 731
Study 18091485 — intervention group
Group type: COMPARATOR
Intervention: Routine care in occupational or primary healthcare services
Number of subjects: 731
Study 18091485 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary lifestyle interventions for hypertension (subgroup analysis)
Number of subjects: 731
Study 16296924 — intervention group
Group type: EXPERIMENTAL
Intervention: Kampo therapy for 12 weeks
Number of subjects: 173
Study 12027847 — intervention group
Group type: EXPERIMENTAL
Intervention: +20 cmH(2)O
Number of subjects: 11
Study 12027847 — intervention group
Group type: EXPERIMENTAL
Intervention: +30 cmH(2)O
Number of subjects: 11
Study 12027847 — intervention group
Group type: EXPERIMENTAL
Intervention: MBAME
Number of subjects: 11
Study 10726112 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 13
Study 10726112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 8824645 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose (1 cup of milk)
Number of subjects: 0
Study 8824645 — intervention group
Group type: COMPARATOR
Intervention: Lactose-hydrolyzed control (1 cup of milk)
Number of subjects: 0
Study 8824645 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose (1 L of milk)
Number of subjects: 0
Study 8824645 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hydrolyzed milk and lactase preparations
Number of subjects: 0
Study 1775676 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release salbutamol (SCR) 8 mg twice daily for 6 weeks
Number of subjects: 58
Study 1775676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 7318626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole treatment in 112 patients
Number of subjects: 457
Study 7318626 — intervention group
Group type: COMPARATOR
Intervention: Neomycin-erythromycin combined with cephalothin in 151 patients
Number of subjects: 457
Study 7318626 — intervention group
Group type: COMPARATOR
Intervention: Matched control patients (141 patients)
Number of subjects: 457
Study 31395808 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy (kinesitherapy with therapy dog)
Number of subjects: 52
Study 31395808 — intervention group
Group type: COMPARATOR
Intervention: Kinesitherapy (without therapy dog)
Number of subjects: 52
Study 28237053 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological momentary assessment (EMA) text messages
Number of subjects: 30
Study 26348788 — intervention group
Group type: EXPERIMENTAL
Intervention: OMSC+Performance Coaching Group
Number of subjects: 0
Study 26348788 — intervention group
Group type: COMPARATOR
Intervention: OMSC Group
Number of subjects: 0
Study 23799706 — intervention group
Group type: EXPERIMENTAL
Intervention: iWell OSN
Number of subjects: 349
Study 23799706 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 349
Study 21836369 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 minutes intensive resistance program at 70%-80% of 1RM
Number of subjects: 34
Study 19299682 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic conditioning
Number of subjects: 149
Study 19299682 — intervention group
Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 149
Study 17582255 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole-based 1 week triple therapy
Number of subjects: 105
Study 17582255 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole-based 2 weeks triple therapy
Number of subjects: 105
Study 15636562 — intervention group
Group type: EXPERIMENTAL
Intervention: Prestige II Cervical Disc
Number of subjects: 55
Study 15636562 — intervention group
Group type: COMPARATOR
Intervention: Iliac crest autograft fusion
Number of subjects: 55
Study 16154059 — intervention group
Group type: EXPERIMENTAL
Intervention: Rose tea
Number of subjects: 130
Study 16154059 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study 10690135 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 30
Study 10690135 — intervention group
Group type: COMPARATOR
Intervention: Propofol anaesthesia
Number of subjects: 30
Study 8912799 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritanserin
Number of subjects: 45
Study 8912799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 1907549 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam, 20 mg day‐1
Number of subjects: 30
Study 1907549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 6870379 — intervention group
Group type: EXPERIMENTAL
Intervention: Halsted radical mastectomy
Number of subjects: 311
Study 6870379 — intervention group
Group type: COMPARATOR
Intervention: Modified radical mastectomy
Number of subjects: 311
Study 30776457 — intervention group
Group type: EXPERIMENTAL
Intervention: smartphone application (PocketCPR)
Number of subjects: 100
Study 30776457 — intervention group
Group type: EXPERIMENTAL
Intervention: dispatcher-assisted telephone CPR
Number of subjects: 100
Study 30776457 — intervention group
Group type: COMPARATOR
Intervention: uninstructed CPR
Number of subjects: 100
Study 30776457 — intervention group
Group type: EXPERIMENTAL
Intervention: dispatcher-assisted telephone CPR combined with smartphone app
Number of subjects: 100
Study 28629397 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of renal replacement therapy (RRT)
Number of subjects: 0
Study 28629397 — intervention group
Group type: EXPERIMENTAL
Intervention: Late initiation of renal replacement therapy (RRT)
Number of subjects: 0
Study 28629397 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitive biomarker panel for AKI diagnosis
Number of subjects: 0
Study 26926372 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human thrombopoietin (rhTPO) combined with high-dose dexamethasone (40 mg intravenously d1-4) and rhTPO (300 U·kg(‐1)·d(‐1) subcutaneously d1-14)
Number of subjects: 59
Study 26926372 — intervention group
Group type: COMPARATOR
Intervention: High-dose dexamethasone (40 mg intravenously d1-4)
Number of subjects: 59
Study 24570273 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry juice concentrate (30 ml diluted to 250 ml with water)
Number of subjects: 47
Study 22563640 — intervention group
Group type: EXPERIMENTAL
Intervention: Live supervision via tele-conferencing (TCS)
Number of subjects: 58
Study 22563640 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard tape-based supervision (Tape)
Number of subjects: 58
Study 22563640 — intervention group
Group type: COMPARATOR
Intervention: Workshop training alone
Number of subjects: 58
Study 19495957 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0
Study 19495957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17301566 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon and ribavirin
Number of subjects: 35
Study 17301566 — intervention group
Group type: COMPARATOR
Intervention: standard interferon and ribavirin
Number of subjects: 35
Study 17301566 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV RNA < 50 IU/ml at week 4
Number of subjects: 35
Study 17301566 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV RNA < 600 IU/ml at week 4
Number of subjects: 35
Study 17301566 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV RNA > 50 IU/ml at week 4
Number of subjects: 35
Study 17301566 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV RNA > 600 IU/ml at week 4
Number of subjects: 35
Study 15060416 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Number of subjects: 0
Study 15060416 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 200/0.5
Number of subjects: 0
Study 15060416 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% modified gelatine
Number of subjects: 0
Study 11585082 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (0.2 mg/kg every 8 h)
Number of subjects: 32
Study 11585082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 9827406 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Dimer test with a cutoff value below 2 micrograms/ml
Number of subjects: 103
Study 9827406 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Dimer test with a cutoff value over 4 micrograms/ml
Number of subjects: 103
Study 9827406 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Dimer test results correlation
Number of subjects: 103
Study 8003650 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 46
Study 8003650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 29417832 — intervention group
Group type: COMPARATOR
Intervention: Supervised group-based exercise (Group B)
Number of subjects: 65
Study 29417832 — intervention group
Group type: COMPARATOR
Intervention: Internet-based exercise (Group C)
Number of subjects: 65
Study 28511647 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved cookstove (low‐smoke chulha)
Number of subjects: 250
Study 28511647 — intervention group
Group type: COMPARATOR
Intervention: Traditional cookstove (chulha) or a combination of traditional stove and kerosene/diesel stove
Number of subjects: 250
Study 24303810 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Behavioral Couples Therapy (TBCT)
Number of subjects: 134
Study 24303810 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couples Therapy (IBCT)
Number of subjects: 134
Study 23715755 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep duration (less than 6.5 h, n=21)
Number of subjects: 79
Study 23715755 — intervention group
Group type: COMPARATOR
Intervention: Longer sleep duration (above 6.5 h, n=58)
Number of subjects: 79
Study 23715755 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondipping pattern of blood pressure
Number of subjects: 79
Study 20921876 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAS-cog12 (including delayed recall)
Number of subjects: 370
Study 20921876 — intervention group
Group type: COMPARATOR
Intervention: ADAS-cog11 (standard 11-item scale)
Number of subjects: 370
Study 20921876 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed Recall (DR) assessment
Number of subjects: 370
Study 19169599 — intervention group
Group type: EXPERIMENTAL
Intervention: SenseWear Armband
Number of subjects: 21
Study 19169599 — intervention group
Group type: COMPARATOR
Intervention: Factorial Method
Number of subjects: 21
Study 19169599 — intervention group
Group type: EXPERIMENTAL
Intervention: Spearman's Correlation
Number of subjects: 21
Study 16497510 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 12072
Study 16497510 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 12072
Study 12553852 — intervention group
Group type: EXPERIMENTAL
Intervention: alefacept (0.025, 0.075, or 0.150 mg/kg)
Number of subjects: 229
Study 12553852 — intervention group
Group type: EXPERIMENTAL
Intervention: alefacept
Number of subjects: 229
Study 12553852 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 229
Study 10674226 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention (daily distribution of two oral supplements, each containing 200 kcal for 15 days)
Number of subjects: 672
Study 10674226 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nutritional intervention)
Number of subjects: 672
Study 9075033 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 1:200,000 epinephrine plus 30 micrograms/kg butorphanol (Group 2)
Number of subjects: 200
Study 9075033 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine with 1:200,000 epinephrine (Group 1)
Number of subjects: 200
Study 8369008 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitex agnus castus preparation (20 mg daily)
Number of subjects: 52
Study 8369008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 2878676 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral xamoterol (200 mg twice daily)
Number of subjects: 12
Study 2878676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31948296 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ketamine
Number of subjects: 303
Study 31948296 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemic ketamine
Number of subjects: 303
Study 31948296 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 303
Study 29912350 — intervention group
Group type: EXPERIMENTAL
Intervention: iReadMore training with anodal transcranial direct current stimulation
Number of subjects: 21
Study 29912350 — intervention group
Group type: COMPARATOR
Intervention: iReadMore training with sham stimulation
Number of subjects: 21
Study 29912350 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation
Number of subjects: 21
Study 29912350 — intervention group
Group type: EXPERIMENTAL
Intervention: iReadMore training
Number of subjects: 21
Study 26992050 — intervention group
Group type: EXPERIMENTAL
Intervention: FVOO (500 ppm)
Number of subjects: 33
Study 26992050 — intervention group
Group type: EXPERIMENTAL
Intervention: FVOOT (250 ppm olive oil polyphenols and 250 ppm thyme polyphenols)
Number of subjects: 33
Study 26992050 — intervention group
Group type: COMPARATOR
Intervention: VOO (standard virgin olive oil)
Number of subjects: 33
Study 24974387 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 U of vitamin D3
Number of subjects: 105
Study 24974387 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,000 U of vitamin D3
Number of subjects: 105
Study 24974387 — intervention group
Group type: EXPERIMENTAL
Intervention: 4,000 U of vitamin D3
Number of subjects: 105
Study 24974387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 21786130 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0-2.0 Gz intermittent artificial gravity with 40 W of ergometric workload every day (countermeasure group, CM)
Number of subjects: 12
Study 21786130 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 12
Study 20623037 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 23
Study 20623037 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study 18162494 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 342
Study 18162494 — intervention group
Group type: COMPARATOR
Intervention: Advanced Moist Wound Therapy (AMWT)
Number of subjects: 342
Study 16398603 — intervention group
Group type: EXPERIMENTAL
Intervention: Roll-stretch massage
Number of subjects: 10
Study 16398603 — intervention group
Group type: EXPERIMENTAL
Intervention: Shiatsu massage
Number of subjects: 10
Study 16398603 — intervention group
Group type: EXPERIMENTAL
Intervention: Beat massage
Number of subjects: 10